Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Urol Oncol. 2017 Nov 11;37(1):12–17. doi: 10.1016/j.urolonc.2017.10.012

Table 2.

Enrichment of common mutations (≥5% frequency among cohort) comparing patients with recurrence or death of disease to those who were alive and free of recurrence and survival analysis of patients with these mutations.

Enrichment of gene mutation in patients tumors with recurrence or death Survival Analysis Comparing patients with the mutation to wild-type
Mutation Fischer Exact Unadjusted Adjusted P-value Log-Rank Unadjusted Adjusted P-Value
VHL 1 1 0.676 0.676
PBRM1 0.155 0.233 0.302 0.422
SETD2 0.014 0.087 0.023 0.071
BAP1 0.073 0.146 0.050 0.100
KDM5C 0.033 0.101 0.005 0.033
MTOR 0.200 0.241 0.351 0.422